Latest On-Demand Webinars

Far too many forays into managed lab services focus purely on reducing the existing cost of service. While cost reductions can and should be one of the arrows in the service providers’ quiver, it shouldn’t be the only one…or the most important one.

A well-designed and implemented managed services program should be one that grows value over time and constantly evolves to ensure that clients are able to spend more time focused on their core scientific activities.

This webinar will be a helpful exercise for key stakeholders to help them get past the basic economics of selecting a provider and help guide them into partnerships that accelerate adoption and unmask far greater and more impactful value.

This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.

A long-standing concern for neuroscientists studying specific cell types in vivo is whether cell isolation from CNS tissue induces ex vivo activational artifacts that confound experimental interpretations.

Analyzing lipids can be a challenge but combining tandem mass spectra obtained from electron-activated dissociation (EAD) can make the process easier. In fact, over 1000 lipids can be analyzed by ballistic data-dependent acquisition liquid chromatography-mass spectrometry. This methodology produces a large number of high-quality EAD fragmented spectra, making annotation the limiting factor, but combinatorial fragmenters can be used to effectively solve this challenge.

In this webinar, we demonstrate how the ZenoTOF 7600 system can be used in a workflow for the routine analysis of lipids that enables the resolution of sn-isomerism and double bond positions from high-throughput EAD mass spectrometry data.

Alzheimer’s disease is the most common form of neurodegenerative disease, estimated to contribute to 60–70% of all cases of dementia worldwide. Increasing evidence suggests that neuroinflammation, primarily mediated by microglia, contributes to the onset and progression of Alzheimer’s disease.

Developing a small molecule active pharmaceutical ingredient (API) is often a risky process. Reaching the goal, be it first in human studies or commercial manufacture, requires data and material without incurring unnecessary delays or impact on costs. Therefore, it’s important to start thinking about process steps and scalability early.

Map proteins, examine metabolic activity and dig deeper into cellular biology by adding spatial localization to your current methodologies. In this webinar, we’ll showcase this novel workflow, highlighting the benefits it can bring to your research.

The field of mass spectrometry has advanced tremendously over the last decade on both the hardware as well as the software side. Nevertheless, we still do not use the full capacity of the acquired proteomic data and several layers of information get lost in typical label-free quantification data-dependent acquisition proteomic datasets. A major source of this information loss is the presence of chimeric spectra, which contain fragment ions from multiple peptides, and the inability to fully interpret them.

In this webinar, we explore how the CHIMERYS intelligent search algorithm gives us a handle to elucidate the hidden traces within chimeric spectra. We’ll also discuss how CHIMERYS increases instrument efficiency and protein identification rates through deconvolution of chimeric spectra, enabling new data acquisition strategies with wide-window acquisition.

Histology has a crucial role throughout the drug discovery and development pipeline, from early-stage R&D to clinical trials.

In this webinar, Dr. Catherine Houlihan, will describe an unrecognized case of viral hemorrhagic fever imported into the UK and the important lessons learned for the emergency clinicians, GPs, virologists, infection specialists and public health doctors.